GeoVax Chief Scientific Officer to Deliver Two Talks at World Vaccine Congress / Presentations Will Focus on the Broad Utility of GeoVax's Vaccine Platform Against Emerging Infectious Diseases and Cancer
ATLANTA, GA -- (Marketwired) -- 10/09/17 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer, Farshad Guirakhoo, PhD,...
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: GeoVax Chief Scientific Officer to Deliver Two Talks at World Vaccine Congress / Presentations Will Focus on the Broad Utility of GeoVax's Vaccine Platform Against Emerging Infectious Diseases and Cancer
NEXT ARTICLE
More From BioPortfolio on "GeoVax Chief Scientific Officer to Deliver Two Talks at World Vaccine Congress / Presentations Will Focus on the Broad Utility of GeoVax's Vaccine Platform Against Emerging Infectious Diseases and Cancer"